From the Breakthroughs Blog: CDC
GHTC’s response to COVID-19
The COVID-19 pandemic is a global health crisis affecting populations around the world. GHTC is tracking and responding to the pandemic through US and multilateral efforts.
Research Roundup: Ebola outbreak wanes, remdesivir prevents MERS coronavirus disease in monkeys, and Trump's budget would cut global health programs
Research Roundup: Vaccine candidate for gestational malaria, FDA fast-tracks coronavirus diagnostic, and Zika vaccine induces potent Zika and dengue antibodies
Congress passes final FY20 spending packages marked by continued support for global health R&D
Faces of Innovation: Dan Littlefield, researcher at Modality Solutions
Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dan Littlefield, who we met at the American Society of Tropical Medicine and Hygiene Annual Conference. Dan co-founded a cold-chain engineering company that worked with the Centers for Disease Control and Prevention and the Biomedical Advanced Research and Development Authority to distribute Ebola vaccines for clinical trials in Sierra Leone.
Faces of Innovation: Dr. Aileen Marty, researcher at Florida International University
Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Aileen Marty, who we met at the American Society of Tropical Medicine and Hygiene Annual Conference. Dr. Marty works at Florida International University and serves on the President’s Advisory Council for Combating Antibiotic-Resistant Bacteria.
Faces of Innovation: Dr. Heinz Weidenthaler, researcher at Bavarian Nordic
Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Heinz Weidenthaler, who we met at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Conference, who developed a smallpox and monkeypox vaccine with Bavarian Nordic.
Faces of Innovation: Dr. Mary Kamb, researcher at CDC
Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Mary Kamb, who we met at the American Society of Tropical Medicine and Hygiene Annual Conference, who leads the Elimination and Control Epidemiology team at the Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria.
Faces of Innovation: Mohammad Ariful Islam, researcher at icddr,b
Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Mohammad Ariful Islam, who we met at the American Society of Tropical Medicine and Hygiene Annual Conference. Ariful researches influenza in Bangladesh with funding from the US Centers for Disease Control and Prevention.
Faces of Innovation: Dr. Mark Kortepeter, researcher at University of Nebraska
Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Mark Kortepeter, who we met at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Conference, who does research on emerging infectious diseases at the University of Nebraska in Lincoln.
Research Roundup: the threat of antibiotic resistant infections, J&J Ebola vaccine roll out in DRC, and Merck Ebola vaccine granted marketing approval by European Commission
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Members of Congress push back at President’s budget cuts to global health research
The Trump administration’s budget request for fiscal year 2020 (FY20) includes cuts that—if enacted—would hamstring the research and development (R&D) of new global health technologies. Since the release of the budget request in early March, however, lawmakers from both parties have expressed their commitment to shielding critical funding strings from the president’s scissors.
Five issues to watch in US global health R&D policy in 2018
2018 is shaping up to be another important year for US policy related to global health and medical research. As Congress returns for a busy work session and the White House continues to roll out policy reforms, here are the top five issues GHTC will be following in 2018.
Celebrating ten years of GHTC & a decade of progress in global health innovation
As we close out our 10th anniversary year, we wanted to take a moment to reflect on our shared progress and celebrate the headlines and moments that shaped global health R&D over the past decade. Check out some of the highlights...
Global health and medical research saved from spending cuts in FY17 budget agreement
What global health R&D advocates need to know about the FY2017 budget agreement.
Research Roundup: Breaking down Zika and opportunities, challenges surrounding global immunization
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
New information for innovation: Antimicrobial Resistance Isolate Bank
A new tool from the US Centers for Disease Control and Prevention is helping researchers develop diagnostic tests and antibiotics to combat the growing problem of antibiotic resistance.
From DC to Atlanta: Becoming Better Advocates for CDC Global Health Programs on Capitol Hill
Global health advocates traveled to the US Centers for Disease Control and Prevention last month. Here's what they learned about the agency's work.
President will redirect Ebola funds for Zika, but where is the money from and where will it go?
The Administration announced that it will transfer nearly $600 million in remaining Ebola funds to fight the growing threat of Zika virus. But many questions remain. Where is the money going? What accounts is it coming from? And what does this mean for the Global Health Security Agenda?